Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-20-016923
Filing Date
2020-08-28
Accepted
2020-08-28 16:05:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G 156383
  Complete submission text file 0001493152-20-016923.txt   157843
Mailing Address STERN AEGIS VENTURES 810 7TH AVENUE 22ND FLOOR NEW YORK NY 10019
Business Address
STERN ADAM K (Filed by) CIK: 0001403497 (see all company filings)

Type: SC 13G

Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
Kintara Therapeutics, Inc. (Subject) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-87181 | Film No.: 201147897
SIC: 2834 Pharmaceutical Preparations